Anorexia Nervosa: A Unified Neurological Perspective
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The roles of corticotrophin-releasing factor (CRF), opioid peptides, leptin and ghrelin in anorexia nervosa (AN) were discussed in this paper. CRF is the key mediator of the hypothalamo-pituitary-adrenal (HPA) axis and also acts at various other parts of the brain, such as the limbic system and the peripheral nervous system. CRF action is mediated through the CRF1 and CRF2 receptors, with both HPA axis-dependent and HPA axis-independent actions, where the latter shows nil involvement of the autonomic nervous system. CRF1 receptors mediate both the HPA axis-dependent and independent pathways through CRF, while the CRF2 receptors exclusively mediate the HPA axis-independent pathways through urocortin. Opioid peptides are involved in the adaptation and regulation of energy intake and utilization through reward-related behavior. Opioids play a role in the addictive component of AN, as described by the "auto-addiction opioids theory". Their interactions have demonstrated the psychological aspect of AN and have shown to prevent the functioning of the physiological homeostasis. Important opioids involved are β-lipotropin, β-endorphin and dynorphin, which interact with both µ and κ opioids receptors to regulate reward-mediated behavior and describe the higher incidence of AN seen in females. Moreover, ghrelin is known as the "hunger" hormone and helps stimulate growth hormone (GH) and hepatic insulin-like-growth-factor-1(IGF-1), maintaining anabolism and preserving a lean body mass. In AN, high levels of GH due to GH resistance along with low levels of IGF-1 are observed. Leptin plays a role in suppressing appetite through the inhibition of neuropeptide Y gene. Moreover, the CRF, opioid, leptin and ghrelin mechanisms operate collectively at the HPA axis and express the physiological and psychological components of AN. Fear conditioning is an intricate learning process occurring at the level of the hippocampus, amygdala, lateral septum and the dorsal raphe by involving three distinct pathways, the HPA axis-independent pathway, hypercortisolemia and ghrelin. Opioids mediate CRF through noradrenergic stimulation in association with the locus coeruleus. Furthermore, CRF's inhibitory effect on gonadotropin releasing hormone can be further explained by the direct relationship seen between CRF and opioids. Low levels of gonadotropin have been demonstrated in AN where only estrogen has shown to mediate energy intake. In addition, estrogen is involved in regulating µ receptor concentrations, but in turn both CRF and opioids regulate estrogen. Moreover, opioids and leptin are both an effect of AN, while many studies have demonstrated a causal relationship between CRF and anorexic behavior. Moreover, leptin, estrogen and ghrelin play a role as predictors of survival in starvation. Since both leptin and estrogen are associated with higher levels of bone marrow fat they represent a longer survival than those who favor the ghrelin pathway. Future studies should consider cohort studies involving prepubertal males and females with high CRF. This would help prevent the extrapolation of results from studies on mice and draw more meaningful conclusions in humans. Studies should also consider these mechanisms in post-AN patients, as well as look into what predisposes certain individuals to develop AN. Finally, due to its complex pathogenesis the treatment of AN should focus on both the pharmacological and behavioral perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central nervous system control of food intake and body weight
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. (2006) · Nature · doi:10.1038/nature05026 · Cited by 2,503
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494 · cited 2×
“Ghrelin is orexigenic and adipogenic in action (93,111-113,115,316), while leptin is anorexigenic and supports adipolysis (317,318).”
BackgroundResultSpiegel, K., Tasali, E., Penev, P., & Cauter, E. V. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-11-200412070-00008 · Cited by 2,459
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Hypothalamic integration: organization of the paraventricular and supraoptic nuclei
Swanson, L. W., & Sawchenko, P. E. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.001413 · Cited by 1,991
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Human emotion and memory: Interactions of the amygdala and hippocampal complex
Phelps, E. A. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.015 · Cited by 1,577 · cited 1×
“The amygdala is responsible for causing reactions of arousal, attention, fear and rage associated with sympathetic nervous system (SNS) activation (69).”
BackgroundThe role of neuropeptide Y in the antiobesity action of the obese gene product
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., et al. (1995) · Nature · doi:10.1038/377530a0 · Cited by 1,498
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Sweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131 · cited 2×
“Both receptors have shown to activate the initial signaling pathways (177-179), but only the CRF2 receptors promote associative and stress-related learning (176,180-182).”
BackgroundMechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074 · cited 8×
“Therefore, the locus coeruleus plays an “integrative role” within the CNS, endocrine system, autonomic system and the behavioral system due to its various connections and the presence of immunoreactive CRF and CRF receptors (40).”
BackgroundInfluentialTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919 · cited 1×
“The CRF1 receptors are found in the cerebral cortex and the anterior lobe of the pituitary gland mediating anxiogenic effects of CRF (45-54), while the CRF2 receptors have been found in the ventromedial hypothalamus (VMH) and the paraventricular nucleus of the hypothalamus (PVNH) (34).”
BackgroundSmith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892
Incidence, prevalence and mortality of anorexia nervosa and other eating disorders
Hoek, H. W. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000228759.95237.78 · Cited by 891 · cited 1×
“6% (8,9) with a mortality rate of 5-18% per decade, possibly due to cachexia and suicide (1,10,11).”
BackgroundEffect of fasting on serum leptin in normal human subjects
Boden, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3419 · Cited by 809
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791 · cited 1×
“Accordingly, cytokines have shown to increase leptin (306,307) and decrease ghrelin levels (308).”
BackgroundDhillon, H., Zigman, J. M., Ye, C., Lee, C. E., McGovern, R. A., Tang, V., Kenny, C. D., Christiansen, L. M., White, R. D., Edelstein, E. A., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.021 · Cited by 791 · cited 7×
“The CRF1 receptors are found in the cerebral cortex and the anterior lobe of the pituitary gland mediating anxiogenic effects of CRF (45-54), while the CRF2 receptors have been found in the ventromedial hypothalamus (VMH) and the paraventricular nucleus of the hypothalamus (PVNH) (34).”
BackgroundInfluentialHuman Leptin Levels Are Pulsatile and Inversely Related to Pituitary–Ardenal Function
Licinio, J., Mantzoros, C., Negrão, A. B., Cizza, G., Wong, M.-L., Bongiorno, P. B., Chrousos, G. P., Karp, B., Allen, C., Flier, J. S., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-575 · Cited by 632 · cited 1×
“Leptin secretion follows a circadian rhythm with the greatest secretion seen between midnight to early morning and lowest during early-to-mid-afternoon (123-125).”
BackgroundCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · cited 1×
“CRF has shown to activate the hypothalamo-pituitary-adrenal (HPA) axis and other various parts of the brain, specifically, the limbic system (34,37,38,41).”
BackgroundRivier, C., Rivier, J., & Vale, W. (1986) · Science · doi:10.1126/science.3003907 · Cited by 531 · cited 1×
“When CRF, representing stress/exercise (278-280), was infused intraventricularly over fourteen days, food intake (protein and fat gain), body weight and energy were reduced in male rats.”
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
Muglia, L., Jacobson, L., Dikkes, P., & Majzoub, J. A. (1995) · Nature · doi:10.1038/373427a0 · Cited by 524
Mercer, J. G., Hoggard, N., Williams, L. M., Lawrence, C. B., Hannah, L. T., Morgan, P. J., & Trayhurn, P. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.05161.x · Cited by 460 · cited 1×
“These effects are due to the action of NPY/AgRP on ghrelin and leptin receptors in the hypothalamus (319,320).”
BackgroundPrimary structure of corticotropin-releasing factor from ovine hypothalamus
Spiess, J., Rivier, J., Rivier, C., & Vale, W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6517 · Cited by 424 · cited 2×
“CRF is a 41-amino acid hypothalamic peptide vital for regulating adrenocorticotrophic hormone (ACTH) secretion (32-34) and neuroendocrine and behavioral stress-related responses (35-39).”
BackgroundInhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409 · cited 1×
“Fibroblast growth factor-21 mediates growth hormone (GH) resistance and reduces (insulin-growth-factor-1) IGF-1 levels (26,27).”
BackgroundRadulovic, J., Rühmann, A., Liepold, T., & Spiess, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05016.1999 · Cited by 402 · cited 7×
“Moreover, the hippocampus (173), amygdala (175), dorsal raphe (183) and lateral septum (61), work collectively to produce the fear response.”
BackgroundInfluentialRelapse in anorexia nervosa: a survival analysis
CARTER, J. C., BLACKMORE, E., SUTANDAR-PINNOCK, K., & WOODSIDE, D. B. (2004) · Psychological Medicine · doi:10.1017/s0033291703001168 · Cited by 389
Anorexia Nervosa and Major Depression: Shared Genetic and Environmental Risk Factors
Wade, T. D., Bulik, C. M., Neale, M., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.469 · Cited by 375 · cited 2×
“Moreover, same-sex and opposite-sex twin studies further support the greater incidence of AN in females (9,15-20).”
BackgroundResultBrennan, A. M., & Mantzoros, C. S. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0196 · Cited by 374
Influence of Corticotropin-Releasing Factor on Reproductive Functions in the Rat*
RIVIER, C., & VALE, W. (1984) · Endocrinology · doi:10.1210/endo-114-3-914 · Cited by 356 · cited 1×
“When CRF was injected into the ARCH and VMH of female rats, there was a decline in luteinizing hormone levels and inhibition of sexual behavior, suggesting that CRF mediates sexual behavior (71).”
MethodCounts, D. R., Gwirtsman, H., Carlsson, L. M., Lesem, M., & Cutler, G. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1381372 · Cited by 344
Johnson, J. G., Cohen, P., Kasen, S., & Brook, J. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.545 · Cited by 300 · cited 2×
“This estimate would increase to 90% if patients undergoing profound recovery were to be included (14).”
BackgroundCortisol Secretion and Metabolism in Anorexia Nervosa
Boyar, R. M., Hellman, L. D., Roffwarg, H., Katz, J., Zumoff, B., O'Connor, J., Bradlow, H. L., & Fukushima, D. K. (1977) · New England Journal of Medicine · doi:10.1056/nejm197701272960403 · Cited by 285
Hamrick, M. W., Della-Fera, M. A., Choi, Y.-H., Pennington, C., Hartzell, D., & Baile, C. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050103 · Cited by 268 · cited 1×
“However, leptin treatment in ob/ob mice was shown to reduce bone marrow fat (326-328).”
BackgroundPPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
Guerre-Millo, M., Rouault, C., Poulain, P., André, J., Poitout, V., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Reach, G., & Staels, B. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2809 · Cited by 241
Leptin in humans: lessons from translational research
Blüher, S., & Mantzoros, C. S. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26788e · Cited by 203 · cited 1×
“Leptin secretion follows a circadian rhythm with the greatest secretion seen between midnight to early morning and lowest during early-to-mid-afternoon (123-125).”
BackgroundAntidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00025-3 · Cited by 195 · cited 1×
“The CRF1 receptors are found in the cerebral cortex and the anterior lobe of the pituitary gland mediating anxiogenic effects of CRF (45-54), while the CRF2 receptors have been found in the ventromedial hypothalamus (VMH) and the paraventricular nucleus of the hypothalamus (PVNH) (34).”
BackgroundSawchenko, P. E. (1987) · Brain Research · doi:10.1016/0006-8993(87)90058-8 · Cited by 189
Leptin Rapidly Lowers Food Intake and Elevates Metabolic Rates in Lean and ob/ob Mice ,
Mistry, A. M., Swick, A. G., & Romsos, D. R. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.10.2065 · Cited by 188
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects
Dzaja, A., Dalal, M. A., Himmerich, H., Uhr, M., Pollmächer, T., & Schuld, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00527.2003 · Cited by 184 · cited 1×
“However, sleep curtailment has shown to limit the secretion of both ghrelin and GH (254-256).”
BackgroundAdipocytes and adipose tissue.
Kiess, W., Petzold, S., Töpfer, M., Garten, A., Blüher, S., Kapellen, T., Körner, A., & Kratzsch, J. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.10.002 · Cited by 130 · cited 2×
“Moreover, females demonstrate greater plasma leptin concentrates than males, but these levels significantly decline after menopause (131).”
BackgroundThe anorectic effects of CRH and restraint stress decrease with repeated exposures
Krahn, D. D., Gosnell, B. A., & Majchrzak, M. J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90046-5 · Cited by 122 · cited 10×
“CRF is a 41-amino acid hypothalamic peptide vital for regulating adrenocorticotrophic hormone (ACTH) secretion (32-34) and neuroendocrine and behavioral stress-related responses (35-39).”
BackgroundInfluentialCorticotropin-releasing factor administered intraventricularly to rhesus monkeys
Kalin, N. H., Shelton, S. E., Kraemer, G. W., & McKinney, W. T. (1983) · Peptides · doi:10.1016/0196-9781(83)90117-1 · Cited by 101 · cited 1×
“Intracerebroventricular administration of CRF to rats, dogs and monkey’s activated both the HPA axis and the SNS, with visceral, metabolic (32,33,73) and behavioral changes (32,74).”
BackgroundPenadés (2007) · doi:10.1016/j.eurpsy.2007.03.004 · Cited by 59 · cited 6×
“The first category is the restrictive type (RAN), where patients exhibit “restricted food intake without binge eating or purging,” while the second category is the binge-eating/purging type (BPAN), involving both “binge eating/purging episodes during anorexia and bulimia phases” (3).”
BackgroundInfluential
Cited by
O’Hara, C. B., Campbell, I. C., & Schmidt, U. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.012 · Cited by 274
Impact of the opioid system on the reproductive axis
Böttcher, B., Seeber, B., Leyendecker, G., & Wildt, L. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.009 · Cited by 115
Paolacci, S., Kiani, A. K., Manara, E., Beccari, T., Ceccarini, M. R., Stuppia, L., Chiurazzi, P., Dalla Ragione, L., & Bertelli, M. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1244 · Cited by 47
The importance of the hypothalamo-pituitary-adrenal axis as a therapeutic target in anorexia nervosa
Bou Khalil, R., Souaiby, L., & Farès, N. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.035 · Cited by 26
Metadata
- Authors
- Hasan, T. F., & Hasan, H.
- Venue
- International Journal of Medical Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2011
- Volume
- 8
- Issue
- 8
- Pages
- 679-703
- ISSN
- 1449-1907 (ISSN-L)
- OpenAlex
- W2163546871
- Cited by
- 43
- References
- 44
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.